(Q40688252)

22 September 2017

Suppression of hepatitis B virus enhancer 1 and 2 by hepatitis C virus core protein (English)

1 reference

22 September 2017

1 reference

1 reference

Christian G Schüttler

1

1 reference

22 September 2017

Nicola Fiedler

2

1 reference

22 September 2017

Katja Schmidt

3

1 reference

22 September 2017

Reinald Repp

4

1 reference

22 September 2017

Wolfram H Gerlich

5

1 reference

22 September 2017

Stephan Schaefer

6

1 reference

22 September 2017

1 December 2002

1 reference

22 September 2017

Journal of Hepatology

1 reference

22 September 2017

37

1 reference

22 September 2017

6

1 reference

22 September 2017

855-862

1 reference

Hepatitis C virus core protein: possible roles in viral pathogenesis.

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900296-9

7 January 2021

Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900296-9

7 January 2021

Non-A, non-B hepatitis in chimpanzees: interference with acute hepatitis A virus and chronic hepatitis B virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900296-9

7 January 2021

Interference between non-A, non-B and hepatitis B virus infection in chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900296-9

7 January 2021

Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900296-9

7 January 2021

Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900296-9

7 January 2021

Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900296-9

7 January 2021

High frequency of HCV infection in individuals with isolated antibody to hepatitis B core antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900296-9

7 January 2021

HCV genotype and "silent" HBV coinfection: two main risk factors for a more severe liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900296-9

7 January 2021

Modulation of the trans-suppression activity of hepatitis C virus core protein by phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900296-9

7 January 2021

"Silent" hepatitis B virus mutants are responsible for non-A, non-B, non-C, non-D, non-E hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900296-9

7 January 2021

The enhancer I core region contributes to the replication level of hepatitis B virus in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900296-9

7 January 2021

Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900296-9

7 January 2021

Comparative studies of the core gene products of two different hepatitis C virus isolates: two alternative forms determined by a single amino acid substitution

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900296-9

7 January 2021

Post-translational modification of the hepatitis C virus core protein by tissue transglutaminase

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900296-9

7 January 2021

Clinical significance of hepatitis C virus genotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900296-9

7 January 2021

Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900296-9

7 January 2021

Sequence motifs required for lipid droplet association and protein stability are unique to the hepatitis C virus core protein

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900296-9

7 January 2021

The domains required to direct core proteins of hepatitis C virus and GB virus-B to lipid droplets share common features with plant oleosin proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900296-9

7 January 2021

Functional analysis of a transrepressor domain in the hepatitis C virus core protein

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900296-9

7 January 2021

Transcriptional Activation of the Interleukin-2 Promoter by Hepatitis C Virus Core Protein

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900296-9

7 January 2021

The role of human MBF1 as a transcriptional coactivator

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900296-9

7 January 2021

Identification and characterization of a tissue-specific coactivator, GT198, that interacts with the DNA-binding domains of nuclear receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900296-9

7 January 2021

Domain structure of the NRIF3 family of coregulators suggests potential dual roles in transcriptional regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900296-9

7 January 2021

Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900296-9

7 January 2021

Chicken ovalbumin upstream promoter-transcription factor II, a new partner of the glucose response element of the L-type pyruvate kinase gene, acts as an inhibitor of the glucose response.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900296-9

7 January 2021

Hepatitis C virus core protein-induced loss of LZIP function correlates with cellular transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900296-9

7 January 2021

Processing and functions of Hepatitis C virus proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900296-9

7 January 2021

Hepatitis C virus core protein: intriguing properties and functional relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900296-9

7 January 2021

Site-specific mutation of the hepatitis B virus enhancer II B1 element: effect on virus transcription and replication.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900296-9

7 January 2021

The hepatitis B virus core promoter is strongly activated by the liver nuclear receptor fetoprotein transcription factor or by ectopically expressed steroidogenic factor 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900296-9

7 January 2021

Identification of multiple transcription factors, HLF, FTF, and E4BP4, controlling hepatitis B virus enhancer II.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900296-9

7 January 2021

Transcription repression of human hepatitis B virus genes by negative regulatory element-binding protein/SON

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900296-9

7 January 2021

Integrated hepatitis B virus DNA preserves the binding sequence of transcription factor Yin and Yang 1 at the virus-cell junction

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900296-9

7 January 2021

10.1016/S0168-8278(02)00296-9

Identifiers

DOI

1 reference

22 September 2017

1 reference